This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80011069
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в травні 2007 scientific article published on 01 May 2007 artículu científicu espublizáu en mayu de 2007 wetenschappelijk artikel im Mai 2007 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q80011069-FCF8E05C-58C3-4579-9D96-597BB2AE9F55
wdt:P577
2007-05-01T00:00:00Z
p:P2093
wds:Q80011069-02E7757C-EDCE-4AC8-95FC-63DACCDB5E1B wds:Q80011069-09735C35-9A83-4F88-9716-805DBEBC72A5 wds:Q80011069-5FC3FDA1-1565-4999-BD2C-62C1C296CED0 wds:Q80011069-4AA4CE11-3494-41EB-9EB9-A54E331D2067 wds:Q80011069-9115CA7E-30F0-4BBF-8B01-9A3FBAA24E9C wds:Q80011069-8881FC4A-13B0-42F3-A4DB-C7FB4E64DA16 wds:Q80011069-C939AC46-F1E5-42B5-800B-A4F4CF9E6C27 wds:Q80011069-CC76DBF5-B24D-4261-9ED5-9A07F1A1F324
wdt:P2093
Shigeru Satoh Hideaki Kagaya Kazuyuki Inoue Yoshinori Sagae Toshio Suzuki Hitoshi Tada Masatomo Miura Tomonori Habuchi
rdfs:label
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
skos:prefLabel
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
schema:name
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
p:P1476
wds:Q80011069-0A909ED2-3893-4633-81E9-EBCCD79D471F
wdt:P1476
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
p:P304
wds:Q80011069-6103805B-7D14-49FD-B70F-DAE01D48DDF8
wdt:P304
167-175
p:P31
wds:Q80011069-5E2539BF-D56C-42F8-8D35-228905EEDA87
wdt:P31
wd:Q13442814
p:P921
wds:Q80011069-DD31A061-5A3D-4EF7-AC8D-30305B4379FC
wdt:P921
wd:Q3515
p:P698
wds:Q80011069-96743080-065D-40FF-8D8B-4A99D4DC667B
wdtn:P698
n10:17377957
wdt:P698
17377957
p:P1433
wds:Q80011069-4050DBD0-9649-4A7E-88DF-A4A37DF5F02D
wdt:P1433
wd:Q15766879
p:P433
wds:Q80011069-1BE1A43D-56AA-4952-87AE-267F7B60B12B
p:P478
wds:Q80011069-E70BD0A9-69B0-460D-85C8-FA737904F6FB
wdt:P433
4
wdt:P478
28
p:P356
wds:Q80011069-E788A5A5-678F-4BC9-ABBE-51774F9CD2D0
wdtn:P356
n12:BDD.544
wdt:P356
10.1002/BDD.544